GLP-1 maintenance dosing: what 'finding your sweet spot' actually means

What did @simplybridget12 actually say?

The creator made a specific and confident claim: GLP-1 maintenance isn't one-size-fits-all. She described using doses ranging from weekly to monthly, said it's "completely normal to fluctuate between five to 10 LBs" during maintenance, and shared that going biweekly personally brought back inflammation and heavy menstrual cycles. Her core advice was to build habits you can sustain long-term, not just habits that work while you're motivated.

She also framed the psychological side honestly: the motivation that drives early weight loss tends to disappear once you hit your goal, and that's where most people struggle. That's a point worth taking seriously, and it's one the clinical literature largely agrees with.

Does the science back this up?

Partially, yes. The idea that maintenance requires individualized dosing is supported by real evidence, but the specifics she described, like monthly injections of semaglutide, are not standard clinical practice and lack trial-level backing.

The STEP 4 trial (Rubino et al., 2021, New England Journal of Medicine) is the clearest reference point here. Participants who continued semaglutide 2.4 mg weekly maintained their weight loss, while those who switched to placebo regained about two-thirds of lost weight within a year. The trial did not test extended dosing intervals. Monthly or biweekly dosing of semaglutide specifically has not been validated in randomized controlled trials. The pharmacokinetics of semaglutide, which has a half-life of roughly seven days, are designed around weekly administration. Stretching that to monthly intervals would produce significantly lower and more variable plasma concentrations. Whether that's sufficient for appetite suppression and weight maintenance in a given individual is genuinely unknown from a data standpoint.

Her five to ten pound fluctuation claim is consistent with what weight maintenance research generally describes as normal biological variability, not a red flag.

What did they get wrong (or right)?

Let's be direct. The claim that monthly GLP-1 dosing is a legitimate maintenance strategy for some people is unverified. It may work anecdotally, but there are no published trials validating monthly semaglutide or tirzepatide dosing for weight maintenance. Presenting it as a recognized option, alongside weekly and biweekly dosing, without that caveat is misleading to viewers who may take it as clinical permission.

The inflammation and menstrual cycle changes she attributed to stopping biweekly dosing are also worth scrutinizing. GLP-1 receptor agonists do have anti-inflammatory properties, noted in research including Drucker (2022, Cell Metabolism), but whether a two-week dosing gap caused her specific symptoms is impossible to confirm and presents correlation as causation.

What she got right is more substantive. The psychological arc she described, high motivation early, drift after reaching goal, is well-documented. Teixeira et al. (2015, International Journal of Behavioral Nutrition and Physical Activity) identified motivational regulation as a key predictor of long-term weight maintenance. Her emphasis on sustainable habits over restriction is also consistent with behavioral weight management evidence.

What should you actually know?

GLP-1 maintenance is genuinely complicated, and the research community is still working through it. Here's what's actually established.

• Stopping GLP-1 therapy typically leads to weight regain. The STEP 4 data and subsequent real-world studies confirm this is the rule, not the exception.
• No major clinical guideline currently recommends extended dosing intervals, meaning monthly or every-three-weeks dosing, as a standard maintenance approach. If you're considering this, it needs to be a conversation with a licensed prescriber who knows your full history, not a TikTok strategy.
• The five to ten pound fluctuation she mentioned is consistent with normal weight variability and is not a sign of failure.
• Protein intake during maintenance matters. Research by Leidy et al. (2015, American Journal of Clinical Nutrition) supports higher protein diets for preserving lean mass and managing hunger long-term, which aligns with her dietary advice.

The creator speaks from personal experience, which has value. But personal experience is not a clinical protocol, and viewers should not adjust dosing frequency based on this video without medical supervision.